Helen C. Adams's Insider Trades & SAST Disclosures

Helen C. Adams's most recent trade in Immix Biopharma Inc was a trade of 33,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Immix Biopharma Inc
Helen C. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 33,000 33,000 - - Stock Option (Right to Buy)
Immix Biopharma Inc
Helen C. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 87,740 100,740 - 0 Common Stock
Immix Biopharma Inc
Helen C. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 74,241 174,754 - - Common Stock
Immix Biopharma Inc
Helen C. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2023 20,000 20,000 - - Stock Options
Immix Biopharma Inc
Helen C. Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jul 2022 16,000 53,500 - - Stock Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades